Brainsway EBITDA Margin 2018-2025 | BWAY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Brainsway ebitda margin from 2018 to 2025. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Brainsway EBITDA Margin 2018-2025 | BWAY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Brainsway ebitda margin from 2018 to 2025. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$228.6B
Boston Scientific (BSX)	$156.7B
Stryker (SYK)	$149B
EssilorLuxottica (ESLOY)	$142.5B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$49.9B
Haleon (HLN)	$43.5B
ResMed (RMD)	$40.3B
Agilent Technologies (A)	$35.5B
GE HealthCare Technologies (GEHC)	$33.7B
Terumo (TRUMY)	$26.8B
Koninklijke Philips (PHG)	$26.6B
Insulet (PODD)	$23.8B
Zimmer Biomet Holdings (ZBH)	$20.8B
Smith & Nephew SNATS (SNN)	$16.3B
Baxter (BAX)	$12.5B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.9B
Lantheus Holdings (LNTH)	$3.8B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.1B
Haemonetics (HAE)	$2.6B
Curaleaf Holdings (CURLF)	$2.3B
Acuren (TIC)	$2.2B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.9B